AstraZeneca's Nasal Spray Vaccine Failed to Elicit a Strong Immune Response to Covid in an ... - Latest Tweet by Bloomberg

AstraZeneca's nasal spray vaccine failed to elicit a strong immune response to Covid in an early trial, a blow to the UK drug giant’s ambitions for developing an alternative approach to preventing the disease https://t.co/u9W7hPWpoH— Bloomberg (@business) October 11, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)